Total : 5 View more »
Affymetrix and Beckman Coulter have entered into an agreement to offer researchers, co-developed products in microarrays and automated liquid handlers.
http://www.pharmaasia.com/article-7975-affymetrixandbeckmancoulterteamup-asia.html
ORANGE COUNTY, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that the company will present at the following conferences:
Enables breakthrough in human stem cell manipulation for research and for the development of stem cells as therapeutics
ORANGE COUNTY, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. , a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that the company will present at the following
http://www.biospace.com/news_story.aspx?StoryID=154468&full=1
Total : 39 View more »
ORANGE COUNTY, Calif., Nov 23, 2009 /PRNewswire-FirstCall via COMTEX/ --
Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Allan Harris, Beckman Coulter's vice president of strategy, will present at the Piper Jaffray Healthcare Conference on Wednesday, December 2, 2009 at 12:00 p.m. (ET).
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)
The live webcast of Beckman Coulter's presentation can be accessed by visiting their website at www.beckmancoulter.com. To access the webcast select "go to IR" under Investor Relations and find the event listed under "What's Ahead." The webcast will be archived on the company's website for future on-demand replay.
Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent about 78% of the company's 2008 revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.
Contact: Cynthia Skoglund, (714) 773-8213
Manager, Investor Relations
SOURCE Beckman Coulter, Inc.
http://www.beckmancoulter.com
Tags: biomedical california conference health healthcare manufacturer nyse president products revenue
Companies: Beckman Coulter, Inc. (BEC)
Nov 22, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Beckman Coulter (NYSE:BEC) on October 02, 2009 at $66.68.
Since then, Beckman Coulter has returned 3.1% as of Friday's recent price of $64.58. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nyse profit securities trial
Companies: Beckman Coulter, Inc. (BEC)
Nov 17, 2009 (Fresh Brewed Media via COMTEX) --
Beckman Coulter (NYSE: BEC) closed yesterday at $66.79. So far the stock has hit a 52-week low of $35.94 and 52-week high of $71.57. Beckman Coulter stock has been showing support around 65.88 and resistance in the 67.80 range. Technical indicators for the stock are Bullish and S&P gives BEC a positive 4 STAR (out of 5) buy rating. BEC appears on the Investors Observer Momentum Plays list. For a hedged play on this stock, look at a Feb '10 65 covered call (BEC BM) for a net debit in the $62.29 area. That is also the break even stock price for this trade. This covered call has a 95 day duration, provides 6.74% downside protection and a 4.35% assigned return rate for a 16.72% annualized return rate (comparison purposes only). Beckman Coulter has a current annual dividend yield of 1.10%.
ATU-Seven Summits Research Goto www.iotogo.com/18w1 for our free report titled, The 18 Ways To Know When It's Time To Dump A Stock
Tags: nyse research S&P trade yield
Companies: Beckman Coulter, Inc. (BEC)
Oct 30, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Beckman Coulter (NYSE:BEC) on October 02, 2009 at $66.68.
Since then, Beckman Coulter has returned 3% as of today's recent price of $64.65. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nyse profit securities trial
Companies: Beckman Coulter, Inc. (BEC)
Total : 2,058 View more »
Health,...ORANGE COUNTY Calif. July 8 /- Beckman Coulte... ...(Logo: ...,Upcoming,Beckman,Coulter,Investor,Events,Second,Half,of,2009,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news
Many documents on the Beckman Coulter website are in Portable Document Format (PDF). In order to view them, click here to download Adobe Acrobat Reader.
http://www.beckman.com/resourcecenter/literature/BioLit/BioPdf.asp?OrderNumber=A-10484A
Beckman Coulter Inc. offers the new nanoVette microliter accessory for DU 800 and DU 730 UV/Vis Spectrophotometers for DNA and protein applications.
http://www.dddmag.com/Beckman-Coulter-UV-Vis-Spectrophotometers-0711.aspx
Scott Garrett, 57, is President and Chief Executive Officer of Beckman Coulter, Inc. and a member of Beckman Coulter's board of directors. Garrett became CEO in February 2005 and was elected to Beckman Coulter's board of directors in January 2005.
Total : 339 View more »
Beckman Coulter Incorporated. The Group's principal activities are to design, manufacture and market systems, which consist of instruments, chemistries, software and supplies for ...
http://www.corporateinformation.com/Company-Snapshot.aspx?cusip=075811109
Beckman Coulter Incorporated. The Group's principal activities are to design, manufacture and market systems, which consist of instruments, chemistries, software and supplies for ...
http://wrightreports.ecnext.com/coms2/reportdesc_COMPANY_075811109
© Beckman Coulter, Inc. 1998 - 2009 © Beckman Instruments, Inc. 1994, 1995, 1996, 1997 All Rights Reserved. U.S. Government Users Restricted Rights - As per GSA ADP Schedule ...
...ORANGE COUNTY Calif. Oct. 29 /- Beckman Coult...(Logo: a href'http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO'...The call may be accessed by dialing (877) 516-3365 or (706) 679-3246 a...The live call and webcast presentation will be accessible to all
...ORANGE COUNTY Calif. Oct. 26 /- Beckman Coult...The live webcast of Beckman Coulter's presentations can be accessed by...Beckman Coulter Inc. based in Orange County California develops m...(Logo: a
...ORANGECOUNTYCalif.Nov.23FirstCall/--BeckmanCoulterInc.(...(Logo:ahref'http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO'tar...ThelivewebcastofBeckmanCoulter'spresentationcanbeaccessedbyvisitingthe...BeckmanCoulterInc.basedinFullertonCaliforniadevelopsmanufacturesa...,Beckman,Coulter,to,Present